|
Volumn 22, Issue 22, 2001, Pages 2125-2130
|
Coronary restenosis elimination with a sirolimus eluting stent: First European human experience with 6-month angiographic and intravascular ultrasonic follow-up
|
Author keywords
Coronary artery disease; Eluting stent; PTCA; Restenosis prevention; Sirolimus; Stenting
|
Indexed keywords
RAPAMYCIN;
ADULT;
AGED;
ANGIOCARDIOGRAPHY;
ARTERY DIAMETER;
ARTERY INTIMA PROLIFERATION;
ARTICLE;
BRAIN HEMORRHAGE;
CELL CYCLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CORONARY STENT;
DRUG DELIVERY SYSTEM;
DRUG MECHANISM;
ECHOCARDIOGRAPHY;
FEMALE;
FILM COATING;
FOLLOW UP;
HUMAN;
INTRAVASCULAR ULTRASOUND;
MALE;
PRIORITY JOURNAL;
PROTEIN INTERACTION;
QUANTITATIVE DIAGNOSIS;
RESTENOSIS;
SIDE EFFECT;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ADULT;
AGED;
AGED, 80 AND OVER;
BRAZIL;
COATED MATERIALS, BIOCOMPATIBLE;
COHORT STUDIES;
CORONARY ANGIOGRAPHY;
CORONARY ARTERIOSCLEROSIS;
CORONARY RESTENOSIS;
CREATINE KINASE;
CREATINE KINASE, MB FORM;
EQUIPMENT SAFETY;
EUROPE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISOENZYMES;
MALE;
MIDDLE AGED;
PROSTHESIS IMPLANTATION;
SIROLIMUS;
STENTS;
ULTRASONOGRAPHY, INTERVENTIONAL;
|
EID: 0035176865
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1053/euhj.2001.2892 Document Type: Article |
Times cited : (198)
|
References (19)
|